Frances Arnold insider trades: Generate Biomedicines (GENB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Frances reports to the SEC
Open-market buys and sales
45 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | GENB | ↓ Sell | 11,409 | $16.19 | $185K | Direct | Nov 4, 2026 (6d) |
| Oct 29, 2026 | GOOGL | ↓ Sell | 82 | $284.00 | $23K | Direct | Oct 30, 2026 (1d) |
| Sep 30, 2026 | GOOGL | ↓ Sell | 83 | $340.45 | $28K | Direct | Oct 2, 2026 (2d) |
| Sep 1, 2026 | GENB | ↓ Sell | 1,000 | $16.00 | $16K | Direct | Sep 3, 2026 (2d) |
| Aug 28, 2026 | GOOGL | ↓ Sell | 82 | $337.71 | $28K | Direct | Aug 31, 2026 (3d) |
| Jul 30, 2026 | GOOGL | ↓ Sell | 82 | $333.39 | $27K | Direct | Jul 30, 2026 (0d) |
| Jun 30, 2026 | GOOGL | ↓ Sell | 112 | $351.28 | $39K | Direct | Jun 30, 2026 (0d) |
| Mar 30, 2026 | GOOGL | ↓ Sell | 102 | $275.19 | $28K | Direct | Mar 31, 2026 (1d) |
| Mar 2, 2026 | GOOGL | ↓ Sell | 112 | $302.99 | $34K | Direct | Mar 4, 2026 (2d) |
| Jan 29, 2026 | GOOGL | ↓ Sell | 102 | $340.00 | $35K | Direct | Jan 30, 2026 (1d) |
| Dec 31, 2025 | GOOGL | ↓ Sell | 102 | $313.45 | $32K | Direct | Dec 31, 2025 (0d) |
| Dec 1, 2025 | GOOGL | ↓ Sell | 102 | $317.66 | $32K | Direct | Dec 2, 2025 (1d) |
| Oct 30, 2025 | GOOGL | ↓ Sell | 112 | $291.80 | $33K | Direct | Nov 3, 2025 (4d) |
| Sep 30, 2025 | GOOGL | ↓ Sell | 103 | $243.13 | $25K | Direct | Sep 30, 2025 (0d) |
| Aug 28, 2025 | GOOGL | ↓ Sell | 102 | $207.80 | $21K | Direct | Aug 29, 2025 (1d) |
| Jun 30, 2025 | GOOGL | ↓ Sell | 101 | $196.31 | $20K | Direct | Jul 31, 2025 (31d) |
| Jun 30, 2025 | GOOGL | ↓ Sell | 121 | $180.72 | $22K | Direct | Jun 30, 2025 (0d) |
| May 30, 2025 | GOOGL | ↓ Sell | 111 | $172.41 | $19K | Direct | Jun 2, 2025 (3d) |
| Apr 30, 2025 | GOOGL | ↓ Sell | 111 | $159.85 | $18K | Direct | May 1, 2025 (1d) |
| Mar 28, 2025 | GOOGL | ↓ Sell | 111 | $162.42 | $18K | Direct | Mar 31, 2025 (3d) |
| Feb 28, 2025 | GOOGL | ↓ Sell | 121 | $170.30 | $21K | Direct | Feb 28, 2025 (0d) |
| Jan 30, 2025 | GOOGL | ↓ Sell | 110 | $200.00 | $22K | Direct | Jan 30, 2025 (0d) |
| Dec 31, 2024 | GOOGL | ↓ Sell | 111 | $192.49 | $21K | Direct | Jan 2, 2025 (2d) |
| Nov 29, 2024 | GOOGL | ↓ Sell | 111 | $169.98 | $19K | Direct | Dec 2, 2024 (3d) |
| Nov 4, 2024 | GOOGL | ↓ Sell | 441 | $171.06 | $75K | Direct | Nov 4, 2024 (0d) |
| Apr 30, 2024 | GOOG | ↓ Sell | 80 | $167.38 | $13K | Direct | Apr 30, 2024 (0d) |
| Mar 28, 2024 | GOOG | ↓ Sell | 90 | $152.00 | $14K | Direct | Mar 29, 2024 (1d) |
| Feb 29, 2024 | GOOG | ↓ Sell | 100 | $138.22 | $14K | Direct | Feb 29, 2024 (0d) |
| Jan 30, 2024 | GOOG | ↓ Sell | 230 | $154.06 | $35K | Direct | Jan 30, 2024 (0d) |
| Dec 29, 2023 | GOOG | ↓ Sell | 240 | $140.51 | $34K | Direct | Dec 29, 2023 (0d) |
| Nov 30, 2023 | GOOG | ↓ Sell | 230 | $136.40 | $31K | Direct | Nov 30, 2023 (0d) |
| Oct 30, 2023 | GOOG | ↓ Sell | 250 | $124.36 | $31K | Direct | Oct 30, 2023 (0d) |
| Sep 28, 2023 | GOOG | ↓ Sell | 240 | $130.85 | $31K | Direct | Sep 28, 2023 (0d) |
| Aug 30, 2023 | GOOG | ↓ Sell | 230 | $135.56 | $31K | Direct | Sep 1, 2023 (2d) |
| Jul 28, 2023 | GOOG | ↓ Sell | 230 | $130.95 | $30K | Direct | Jul 28, 2023 (0d) |
| Jun 29, 2023 | GOOG | ↓ Sell | 240 | $120.02 | $29K | Direct | Jun 29, 2023 (0d) |
| May 31, 2023 | GOOG | ↓ Sell | 240 | $123.73 | $30K | Direct | May 31, 2023 (0d) |
| May 25, 2023 | GOOG | ↓ Sell | 950 | $125.25 | $119K | Direct | May 26, 2023 (1d) |
| Jul 29, 2022 | GOOG | ↓ Sell | 1,230 | $116.44 | $143K | Direct | Jul 29, 2022 (0d) |
| Feb 4, 2022 | GOOG | ↓ Sell | 50 | $2858.00 | $143K | Direct | Feb 8, 2022 (4d) |
| May 11, 2020 | ILMN | ↓ Sell10b5-1 | 1,503 | $309.11 | $465K | Direct | May 13, 2020 (2d) |
| May 13, 2019 | ILMN | ↓ Sell10b5-1 | 1,503 | $307.95 | $463K | Direct | May 15, 2019 (2d) |
| Mar 15, 2018 | ILMN | ↓ Sell10b5-1 | 250 | $252.26 | $63K | Direct | Mar 15, 2018 (0d) |
| Mar 8, 2018 | ILMN | ↓ Sell10b5-1 | 250 | $241.50 | $60K | Direct | Mar 8, 2018 (0d) |
| May 25, 2017 | ILMN | ↓ Sell10b5-1 | 825 | $174.77 | $144K | Direct | May 26, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GENB insiders
Open-market trades in the last 12 months
About Frances Arnold's insider trades
Frances Arnold is an insider at Generate Biomedicines (GENB). Since May 25, 2017, Frances has reported no open-market purchases and 45 sales worth $2.8M on SEC Form 4. In the last 12 months: 12 sales ($508K).
5 sales (43% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (30 filings), shares returned to the company (1 filing), inherited shares (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GENB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.